Safety and Immunogenicity of an Intranasal Sendai Virus-Based Human Parainfluenza Virus Type 1 Vaccine in 3- to 6-Year-Old Children

Human parainfluenza virus type 1 (hPIV-1) is the most common cause of laryngotracheobronchitis (croup), resulting in tens of thousands of hospitalizations each year in the United States alone. No licensed vaccine is yet available. We have developed murine PIV-1 (Sendai virus [SeV]) as a live Jenneri...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Clin Vaccine Immunol
المؤلفون الرئيسيون: Adderson, Elisabeth, Branum, Kristen, Sealy, Robert E., Jones, Bart G., Surman, Sherri L., Penkert, Rhiannon, Freiden, Pamela, Slobod, Karen S., Gaur, Aditya H., Hayden, Randall T., Allison, Kim, Howlett, Nanna, Utech, Jill, Allay, Jim, Knight, James, Sleep, Susan, Meagher, Michael M., Russell, Charles J., Portner, Allen, Hurwitz, Julia L.
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society for Microbiology 2015
الموضوعات:
Vaccines
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4340902/
https://ncbi.nlm.nih.gov/pubmed/25552633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00618-14
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة